chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he fell and broke his elbow; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and JOINT INJURY (he fell and broke his elbow) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for Blood pressure, MELOXICAM for Pain, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL PALMITATE, RIBOFLAVIN, THIAMINE MONONITRATE (MULTIVITAMIN 6) and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 18-Feb-2021, the patient experienced JOINT INJURY (he fell and broke his elbow). The patient was treated with Surgery for Joint injury. On 15-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, JOINT INJURY (he fell and broke his elbow) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    This case was linked to MOD-2021-116476 (Patient Link).
Pt vaccinated w/3rd dose of Hepatitis B IV instead of IM on approx 5APR91; developed sx of serum sickness which included fever, malaise & SOB; CXR showed diffuse nodular alveolar infiltrates; Md felt poss going into resp failure;
pt recvd vax; lt nerve paralysis noted 10 days p/ vax given;
Pt vaccinated w/MMR/HIB & 4 wks later developed aplastic anemia.
Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day; vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day) and PRODUCT STORAGE ERROR (vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced PRODUCT STORAGE ERROR (vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day). On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day) and PRODUCT STORAGE ERROR (vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported It was reported that the vial did not undergo any temperature excursions.  It was reported that there was a correction only 1 bottle of Moderna Lot Number 016J21-2A that was opened and administered on 18-Feb-2022 to 5 people. No Treatments were reported.   This case was linked to MOD-2022-501758, MOD-2022-501759 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2022: Follow up information received, case updated to spontaneous from invalid, patient information added.
Dizziness, weakness, arms very sore.  Left arm tender, mild swelling - local reaction.  Rx Benadryl 25 mg QID, cold compresses.  RTO if symptoms get worse or if new concerns.
around 28 hrs after vaccine I began having chest pains, radiating to the left armpit, chills, and shortness of breath making it hard to  talk and breath. The shortness of breath only lasted around 10 minutes and the chest pains lasted 5 hrs
pt rcvd vax; pt devel retinal vasculitis in both eyes;taken to ophtalmologist & pt had clinical evidence of cystoid mascular edema;
I received the first series of the Moderna vaccine on 5/1/2021 at 12:30 pm at the. On May 5th 2021, I began to experience (hear ) a continuous high pitched "pinging" sound in both my ears. Upon investigating this phenomenon, I was able to find information on onset tinnitus after receiving the covid vaccine. I was unaware of this connection and only AFTER investigating this, did I realize there was a connection.   Today is 5/13/2021, and daily I have a  constant audible sharp "pinging" in my ears.  This is a new for me and I have not experienced prolonged constant ringing in my ears in the past.  From a scale from 1-10 ( loudest ), my tinnitus ( sharp constant pinging ) is about a 5 on the scale.  It does not dissipate. I have a Dr.s appointment next week to address this new issue and hope to be advised if I should take the second Moderna vaccine ( which at this time I'm leaning towards not taking it ) as I do not know the long term effects.
Thursday January 7, 2021: Developed a hard lump around the injection site (A week to the day later).  Friday January 8, 2021: Arrived at work and around 9:30 felt short of breath. Had pulse and oxygen checked anyway; Pulse 99 (down from 107) and Oxygen 99. Dismissed it as being in my head. Proceeded through my day and it persevered.  After lunch, still felt short of breath. Contacted Infection Control nurse and was advised to leave work as it was also a COVID symptom.  Went home around 12:15; felt fatigued. Slept all day and night. Saturday January 9, 2021: Minor sore throat, feel as if coming down with a cold.  Back of sinuses felt hot upon breathing.  Bump at injection site gone completely (I massaged it Thursday and Friday). Minor discomfort with breathing; barely noticeable. In the afternoon time around 2pm, sudden and urgent diarrhea that lasted into the evening hours at bed.  Top of stomach burning (inside body). Diarrhea stopped, but nausea remained.  At bedtime, still felt as if coming down with a cold. Sunday January 10, 2021: Woke up feeling as if I was getting over a cold.  Nose stuffy on the side I slept on. Throughout the day, had the sniffles as the stuffiness went away.  Stomach still off; feeling nauseous.  No diarrhea (no bowel movement at all).  Throughout the afternoon tightness in chest/shortness of breath returned.  Towards the evening time still felt as if getting over a cold.  Contacted Human Resources and voice appeared hoarse. Ended phone call.  Touched my face and noticed a huge lump on my chin that felt like the lump at injection site.  Felt like a cyst. About 20 minutes later began to have difficulty swallowing; throat felt tight.  Drank a bottle of water and took two allergy pills with antihistamine.  An hour and a half after taking these,  tightness in throat is still present, but has not progressed any further; in fact, it appears to be slowly fading away.  (It's more like the feeling of having a "lump in your throat" (but I can't physically feel a lump).  The lump on my chin has noticeably diminished in size and is less painful to the touch. COVID test is scheduled for 1/11/21 at 10:30am. It feels as if my body is doing a "systems check."
Friday the 10th, a week after the Moderna booster shot, when I scratched my skin to relieve itching subcutaneous bleeding arose on the site of scratching, which usually never happens to me for any reason.  I've been applying anti-itch ointments since then to prevent further instances.  Also a subcutaneous bleed of an ancient surgical scare erupted in a place I didn't scratch, on that same day, which it also did almost a year ago when I came down with a bad cough from attending jury duty and caught whatever was floating around. (Early COVID? Don't know, but it was a hell of a bad cough with strong colored and sticky production from coughing).   Other than these two instances in this past year, the latest being in the past week, that scar never bleed subcutaneously in any manner since I had an aneurstic cyst removed there when I was about 7 or 8 years old.  It had  been utterly static for decades.    Today, the 15th, my mouth started bleeding from an oral surgery site that hasn't bleed, but had fully healed, by at least May 2021.  It was a small bleed I could stop with compression, but utterly unaccounted for by any act of eating or other pressure on the bleed site before it started bleeding.  I also am uncertain but suspect I had some blood in stool, brownish-red not fully to tar stage of black but not fully red for fresh blood either.    I had only minor hardness and soreness at the injection site which went away the day after the injection otherwise.  I cannot account for mysterious bleeding except for some response to the 3rd booster shot of Moderna.
Varicella outbreak/rash: multiple erythematous papules and multiple vesicles with erythematous borders to scalp, face, trunk, upper extremities and buttocks. Treatment: isolation. 03/26/07-records received from facility for DOS 01/27-01/30/07 DC DX: Viral illness. Received Varicella vaccine 1/16/07, after negative titer-2 weeks later developed rash with typical dewdrop on rose petal type of morphology. Pruritis. Admitted for isolation due to basic training status and concern for contagiousness.
Site: Itching at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash Generalized-Severe, Additional Details: Pt develope a rash on the left side of her body starting from the arm where she received the vaccines from to her stomach. Pt stated rash and itch started same day after received the vaccines but did not inform immunizer used hydrocortisone at home. give pt benadryl and counsel to see a doctor if severe itch and rash does not go away.
pain at the injection site; Rash on left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on left arm) and VACCINATION SITE PAIN (pain at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash on left arm). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE RASH (Rash on left arm) and VACCINATION SITE PAIN (pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included allergy medicines. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Outcome of the event was updated.
the only time patient got sick the only time patient got the poison; The only time I got the flu was the only time I got sick, never again; Based on the additional information received on 05-Nov-2020, the case became valid due o the addition of the suspect vaccine.  Initial information regarding an unsolicited non-valid non-serious case received from a consumer from social media on 29-Sep-2020.  This case involves a patient of an unknown age who got sick (illness) the only time patient got the poison and the only time the got the flu (influenza), never again, while the patient received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medicatrions and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, route and administration site unknown) for prophylactic vaccination.  On an unknown date, the patient developed a non-serious the only time patient got sick the only time patient got the poison (illness) and the only time the patient got the flu, never again (influenza).  No relevant laboratory test was reported.  It was not reported if the patient received a corrective treatment. The outcome was reported as unknown for both events.  There will be no information available on the batch number for this case.  Additional information regarding unsolicited valid non-serious case was received on 05-nov-2020.  The case became valid due to the addition of the suspect vaccine and the event (flu) was also added.  Corresponding fields and narrative were updated accordingly.
An 18-year-old male patient had received an intramuscular right deltoid injection of DECAVAC, lot number U2067DA, and an intramuscular left deltoid injection of MENACTRA, lot number U2632AA, and a subcutaneous left deltoid injection of PNEUMOVAX, lot number 038OU on 02 June 2008 and approximately nine hours later, he developed pain, redness and swelling 3.5 x 2.5 at the left deltoid injection site, left arm numbness and tingling, nausea, dizziness and lightheadedness when standing, and a left axillary lump. The patient was not evaluated by a physician. The patient had not received any other vaccines during the four weeks prior to vaccination however they had received a dose of DECAVAC five months prior on 02 January 2008. the subject's recovery status was not reported and no further information was provided at the time of the report. Follow-up information was received 14 August 2008 from a local health care professional. The report clarified that the initial redness and swelling at the left deltoid injection, site previously described as 3.5 x 2.5, had been in cm. They reported symptoms resolved by 05 June 2008, except for the area of redness which increased to 17 x 9 cm. The patient  had been evaluated by the nurse practitioner on 06 June 2008 and the area of redness had decreased to 4.5 cm in diameter at the time of that evaluation and the patient subsequently recovered from the event date of recovery for the area of redness was not reported. Corrective treatment included ibuprofen, TYLENOL and the application of ice. The diagnosis for the event was reported to have been "localized reaction to vaccine". Follow-up information was received on 18 September 2008 from a health care professional. The reporter clarified that thr injection administered on 02-June 2008 was not part of a primary series. No further information was provided.
I took the first dose of the Covid vaccine Saturday, Sunday I woke up with pain in my injection arm, the worse headache ever, feeling nauseous and my body was so sore. Throughout the day I felt weak, sleepy and got light headed and went to bed. I had no appetite but I was very thirsty. I didn?t eat Sunday. Today (Monday) I woke up with those same issues and more. I have a sore throat it feels tight, I?m dizzy and just feel sick all around and still have no appetite but I?m thirsty and my finger tingle.
High fever; Chills; Queasiness; Malaise; Fatigue; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PYREXIA (High fever), CHILLS (Chills), NAUSEA (Queasiness), MALAISE (Malaise) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (High fever), CHILLS (Chills), NAUSEA (Queasiness), MALAISE (Malaise) and FATIGUE (Fatigue). At the time of the report, PYREXIA (High fever), CHILLS (Chills), NAUSEA (Queasiness), MALAISE (Malaise) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Described by patient very large, raised hot to touch, red. Asked about breathing or swelling of lips or tongue, answered No.
Moderna COVID-19 Vaccine EUA. Within 2 min. of vaccination in my left arm my left leg went numb. A few minutes later my right leg went numb. The numbness disappeared in both legs in about 2.5 hours.
arm is sore / cannot lift it without pain; cannot lift it without pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th June 2020, the patient received the 2nd dose of Shingrix. On 8th June 2020, less than a day after receiving Shingrix, the patient experienced pain in arm and mobility decreased. On an unknown date, the outcome of the pain in arm and mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and arm was sore and cannot lift it without pain.
Information has been received from a 70 year old female with depression, acid reflux, a broken left arm and no allergies who on 10/13/2005, was vaccinated SC in the right arm with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650331/0749P) last dose reportedly received 10 years prior. Concomitant vaccinations on that same day included a dose in the right arm of influenza virus vaccine (unspecified). Other concomitant therapy included esomeprazole magnesium (Nexium), tolterodine tartrate (Detrol) and sertraline HCL Zoloft. The patient reported that on 10/13/2005, she developed chills and swelling and redness around the injection site. No lab diagnostic test were performed as medical attention was not sought. At the time of this report, the patient's events persisted. No further information is available.
Pt recvd measles vax 24AUG76 & on 16DEC90 14 yrs post vax, pt devel temp which persisted x 4 days, cough & a rash which was poss considered to be measles; Pt was seen by MD tx Amoxicillin & Actifed; later recovered;
RN had second step PPD planted yesterday in left forearm, also received MMR in left upper arm. Overnight her arm in area of the PPD "felt like it was on fire, like I had a bee sting". She had no reaction to TUBERSOL at the first step. Has had only one other PPD she can recall in past which was neg. No travel outside country in past year. Mother has hx of + PPD. The area of skin around MMR site is not bothering her.
Rec'd flu vaccine 11/5/14. 12/31/14 - routine prenatal visit - Rt facial palsy began 12/30/14. Retroviral pain, rt eyelid droop, can't smile rt side mouth. 1/5/15 needs meds for pain -> steroidal course.
tested positive for COVID; tested positive for COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (COMIRNATY), administration date 05Jun2021 (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 12Dec2021, outcome "unknown" and all described as "tested positive for COVID". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (12Dec2021) positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
A report has been received from a Physician concerning an 11 year old, Female subject, who had been receiving FLUMIST. FLUMIST started on 19-Sep-2012. On 19-Sep-2012, the patient received 2 doses of FLUMIST five minutes apart. The physician stated that the child did receive 2 full doses of FLUMIST but experienced no side effects. He indicated that after the FLUMIST was ordered for the child a nurse gave a full dose but did not sign that it was given, a second nurse noted FLUMIST needed to be given and gave a full second dose. The outcome of the event of 2 doses of FLUMIST given 5 minutes apart is unknown. The report was considered to be non-serious. Summary of follow-up information received by AstraZeneca/MedImmune on 05-Dec-2012 from physician: Reporter confirmed that patient was given two full dose inadvertently and no adverse event occurred, narrative updated. Corrected report 17-Dec-2012: Reporter details corrected, route, second lot number and expiration date of FLUMIST, coding of event '2 doses of FLUMIST given 5 minutes apart' changed to extra dose administered. Corrected Report on 10-Apr-2014: Ethnic origin added. Second lot number and expiration date added of the suspect drug. Coding of event of 2 doses of FLUMIST given 5 minutes apart changed to inappropriate dose of vaccine administered. Title of the reporter added. Narrative added.
congestion and cough that has been present for the past 4 days. Cough is wet and sometimes productive. Started feeling short of breath with exertion and felt like he was wheezing at times with exertion. No SOB at rest. No chest pain or tightness. Attended wedding over the weekend
Shortness of breath; This is a spontaneous report from a contactable consumer. A non-pregnant female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date, the patient experienced shortness of breath. The patient did not receive any treatment for the reported events. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event shortness of breath. The clinical outcome of the event shortness of breath was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: 1. Narrative "The patient did not receive concomitant medications." updated as "Concomitant medications were not reported". 2. Concomitant Therapy leave blank. 3. Narrative "from a non-contactable consumer" updated to "from a contactable consumer".
Exactly a week after receiving the Pfizer vaccine I noticed a red rash on both of my ankles. Mostly the interior area of the ankle.  There is also some mild swelling. No pain or itching.  I have had no other symptoms since receiving this vaccine, not even a sore arm at the injection site.
patient developed progressive diffuse muscle weakness, altered mental status including excessive drowsiness, decreased oral intake starting on 1/31/2021.  Symptoms continued to worsen overnight and he was evaluated in the emergency room on 2/2/2021 and admitted with dehydration and altered mental status.  He was aggressively hydrated overnight, but showed persistent diffuse muscle weakness, altered mental status with decreased responsiveness progressing, but no focal neurological findings noted.  CT scan of the head on 3/3/2021 showed no findings other than age-related diffuse cerebral atrophy.  The patient did spike a fever to 103 on the morning of 2/3/2021.  CBC, CMP, procalcitonin and lactic acid levels remained normal.  He remains hospitalized in stable condition as of 2/3/2021 @1300.